Hancock Jaffe Laboratories Inc reports results for the quarter ended in March - Earnings Summary

enVVeno Medical

19/05/2021 20:05

* Hancock Jaffe Laboratories Inc  HJLI.OQ  reported a quarterly
adjusted loss of 48 cents​​ per share for the quarter ended
in March. The lone analyst forecast for the quarter was for a
loss of 34 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Hancock Jaffe Laboratories Inc's reported EPS for the quarter
was a loss of 48 cents​.
* The mean earnings estimate of analysts had fallen by
about 78.9% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Hancock Jaffe Laboratories Inc shares had fallen by 16.4% this
quarter and lost 35.6% so far this year.
* The company reported a quarterly loss of $2.77 million.
* Wall Street's median 12-month price target for Hancock Jaffe
Laboratories Inc is $28.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 19 at 07:05 p.m. GMT.
​All figures in US dollars